|
Article Excerpt
Original Source: FD (FAIR DISCLOSURE) WIRE
OPERATOR: Good morning, ladies and gentlemen and thank you for standing by. Welcome to the Cipher Pharmaceuticals fiscal 2008 second quarter results conference call. All participants are in listen-only mode. Following today's presentation instructions will be given for the question-and-answer session. (OPERATOR INSTRUCTIONS) As a reminder, this conference call is being recorded Wednesday, August 13, 2008.
On behalf of the speakers that follow, listeners are cautioned that today's presentation and the responses to questions may contain forward-looking statements within the meaning of the safe harbor provisions of the Canadian provincial securities laws. Forward-looking statements involve risk and uncertainties and undue reliance should not be placed on such statements. Certain material factors or assumptions are implied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
For additional information about factors that may cause actual results to differ materially from expectations, and about material factors or assumptions applied in making forward-looking statements, please consult the MD&A for this quarter when available to you. The risk factor section of the annual information form and Cipher's other filings with the Canadian securities regulators. Cipher does not undertake to update and forward-looking statements. Such statements speak only as of the date made.
I would now like to turn the conference over to Mr. Larry Andrews, President and Chief Executive Officer of Cipher Pharmaceuticals. Please go ahead, sir.
LARRY ANDREWS, PRESIDENT AND CEO, CIPHER PHARMACEUTICALS: Thank you, operator. Good morning and thank you for participating in today's conference call. Joining me today is Norm Evans, our Chief Financial Officer. Earlier this morning we released our financial results for Q2 2008. If did you not receive a copy of the press release, please visit our website at www.cipherpharma.com.
On today's call we'll review our financial results for the quarter and provide an update on our drug development activities. After that we will open the call to your questions. Norm will first...
|
|
More articles from Fair Disclosure Wire
Event Brief of Q3 2008 Brocade Communications Systems, Inc. Earnings C..., August 13, 2008
Event Brief of Q2 2008 Canadian Solar Inc. Earnings Conference Call - ..., August 13, 2008
Event Brief of Q1 2009 Bob Evans Farms Earnings Conference Call - Fina..., August 13, 2008
Event Brief of Toll Brothers 3rd Quarter Outlook Conference Call - Fin..., August 13, 2008
Event Brief of Q3 2008 Gildan Activewear Earnings Conference Call - Fi..., August 13, 2008
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
